MP31 is a micropeptide localised in the mitochondria, it has been found that MP31 disrupts the homeostasis of mitochondria in cancer cells and sensitises GBM cells to chemotherapeutic drugs, therefore, MP31 is promising to be used in the treatment of GBM in the future [124]. The gene discussed is MLDHR; the disease is glioblastoma.